Nicholas C. Robin, Ph.D.
Affiliations: | Pharmacology | University of Washington, Seattle, Seattle, WA |
Area:
Wnt signalingGoogle:
"Nicholas Robin"Mean distance: 17.6 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Randall Moon | grad student | 2014 | University of Washington | |
| (Pharmacologic regulation of Wnt/beta-Catenin Signaling in Stem and Progenitor Cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Robin NC, Agoston Z, Biechele TL, et al. (2014) Simvastatin promotes adult hippocampal neurogenesis by enhancing Wnt/β-catenin signaling. Stem Cell Reports. 2: 9-17 |
| James RG, Bosch KA, Kulikauskas RM, et al. (2013) Protein kinase PKN1 represses Wnt/β-catenin signaling in human melanoma cells. The Journal of Biological Chemistry. 288: 34658-70 |
| Martin PM, Yang X, Robin N, et al. (2013) A rare WNT1 missense variant overrepresented in ASD leads to increased Wnt signal pathway activation. Translational Psychiatry. 3: e301 |
| James RG, Davidson KC, Bosch KA, et al. (2012) WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling. Plos One. 7: e50457 |
| Biechele TL, Kulikauskas RM, Toroni RA, et al. (2012) Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma. Science Signaling. 5: ra3 |
| Biechele TL, Camp ND, Fass DM, et al. (2010) Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma. Chemistry & Biology. 17: 1177-82 |